For Immediate Release

February 12, 2021

Sumitomo Chemical Announces Revisions to Its Financial Forecast
for the Full Year Ending March 31, 2021
Based on recent performance trends, Sumitomo Chemical has made revisions to its consolidated
financial forecast for the full year ending March 31, 2021, previously announced on October 30,
2020, as detailed below.
Revisions to Consolidated Financial Forecast for the Full Year Ending March 31, 2021
(Millions of yen)SalesrevenueCore
operatingincome *OperatingincomeNet income
attributable toowners of theparentEarningsper share(yen)Previous forecast (A)2,215,000

100,000

105,000

30,000

18.35

Revised forecast (B)2,260,000

135,000

110,000

20,00012.23

45,00035,0005,000-10,000

2.0

35.0

4.8

-33.3

2,225,804

132,652

137,51730,926

Variance in amount (B-A)
Variance in percentage (%)
Previous year results(Fiscal 2019)18.91* “Core operating income” excludes gains and losses from non-recurring factors from operating income.

(Reasons for the Revision)
Sales revenue and core operating income are expected to outperform the previously announced
forecast, boosted by the market conditions for Petrochemicals & Plastics sector, and steadyshipment in Pharmaceuticals and IT-related Chemicals sectors.
On the other hand, for non-recurring items which are not included in core operating income we
expect to record impairment loss, after the Phase 3 study of napabucasin in patients withcolorectal cancer failed to achieve primary endpoints in the analysis results, and owing to thereassessment of feasibility of alvocidib under development for acute myelogenous leukemia(AML) and TP-0903 under development for solid tumors. In addition, we revised the foreignexchange rate of the fourth quarter of fiscal 2020 to 105 yen/dollar from 108 yen/dollar, which we
previously estimated. Net income attributable to owners of the parent is expected to fall below thepreviously announced forecast because of foreign exchange loss associated with the appreciationof yen affects.

Cautionary Statement
Statements made in this document with respect to Sumitomo Chemical’s current plans, estimates,strategies and beliefs that are not historical facts are forward looking statements about the future
performance of Sumitomo Chemical. These statements are based on management’s assumptions
and beliefs in light of the information currently available to it, and involve risks and uncertainties.
The important factors that could cause actual results to differ materially from those discussed in
the forward looking statements include, but are not limited to, general economic conditions in
Sumitomo Chemical’s markets; demand for, and competitive pricing pressure on, Sumitomo
Chemical’s products in the marketplace; Sumitomo Chemical’s ability to continue to win
acceptance for its products in these highly competitive markets; and movements of currency
exchange rates.

Information:
Financial Forecast by Segment for the Full Year Ending March 31, 2021
(Millions of yen)
Fiscal 2020
Previous
Forecast (A)Fiscal 2020
Revised
Forecast (B)Variance inAmount (B-A)

Petrochemicals &Plastics

Sales revenue

525,000

570,000

45,000Core operating income-33,000-18,000

15,000

Energy & Functional
Materials

Sales revenue

240,000

240,000－Core operating income

18,00018,000－

Sales revenue

430,000

425,000-5,000Core operating income

36,00040,0004,000

Sales revenue

430,000

425,000-5,000Core operating income

31,00027,000-4,000

Sales revenue

535,000

545,000

10,000Core operating income

51,00065,00014,000

Sales revenue

55,00055,000－Core operating income-3,000

3,000

6,000

2,215,000

2,260,000

45,000100,000

135,000

35,000IT-related Chemicals
Health & CropSciences
Pharmaceuticals
OthersAdjustments
Total

Sales revenue
Core operating income